Abstract
1. 1. Monoamine metabolite measurenients are being increasingly used for making nosological, symptomatological and pharmacological profiles of the affective disorders. 2. 2. A number of unresolved methodological issues question the validity of using baseline metabolite levels for predicting treatment response. 3. 3. Some studies show correlations between baseline metabolite levels and response to treatment with specific antidepressant agents. 4. 4. Effects of antidepressant treatment on metabolite levels may be useful in predicting drug response.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Progress in Neuropsychopharmacology & Biological Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
